Clinical Trials Logo

Clinical Trial Summary

To evaluate the safety of 18F-LNC1007 injection in the diagnosis of suspected tumor, initial stage, or recurrence monitoring; to explore the biological distribution of 18F-LNC1007 injection in patients; To compare the diagnostic efficacy of 18F-LNC1007 injection PET/CT versus 18F-FDG PET/CT imaging in patients with tumor with clinical suspicion, initial stage, or recurrence monitoring.


Clinical Trial Description

This is a prospective, controlled, open-label (with blind members), single-center clinical trial to evaluate the diagnostic efficacy and safety of 18F-LNC1007 injection PET/CT for suspected tumor or tumor initial staging, recurrence monitoring, etc. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06205888
Study type Observational
Source Jinling Hospital, China
Contact
Status Not yet recruiting
Phase
Start date March 1, 2024
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02261415 - The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial Phase 3
Recruiting NCT06450145 - Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL N/A
Active, not recruiting NCT05776732 - Effect of CaviionTM Precaution Medical Adhesive-related Skin Injury in Tumor Patients With PICC Catherizaion N/A
Completed NCT01651182 - Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection Phase 3
Completed NCT03920371 - Evaluation of a Prototype Hand Held Hybrid Gamma Camera N/A
Completed NCT03146624 - Evaluation of Patients Satisfaction of Attachment Retained Versus Clasp Retained Obturators in Unilateral Total Maxillectomy N/A
Recruiting NCT05779514 - Effect of Mirabegron on Promoting Brown Adipose Tissue Activation N/A